Materials and methods:
We conducted a retrospective descriptive and analytical study of 45
patients who were registered in the gynecology-obstetrics department at
HMIMV between April 1, 2020, and August 1, 2022. These pregnant patients
were managed for COVID-19 pneumonia confirmed by real-time polymerase
chain reaction (RT-PCR). The data to be analyzed were recorded on a data
sheet, and we identified 45 files that met our inclusion criteria. For
some patients, we made telephone calls to obtain the remaining
information.
The inclusion criteria for our study were pregnant patients who had been
diagnosed with COVID-19 infection confirmed by RT-PCR on nasopharyngeal
swab samples and were hospitalized in the gynecology-obstetrics and
intensive care unit at HMIMV. We only included cases that met these
criteria in our evaluation form, which was filled in for each case while
ensuring anonymity and encryption of the data.
Our exclusion criteria were non-pregnant patients and pneumonia cases
with COVID-19 cause not confirmed by RT-PCR test. After collecting all
data, we processed it using SPSS software and analyzed it using
headcounts and percentages. This allowed us to draw meaningful
conclusions from the data and better understand the impact of COVID-19
on pregnant patients